Lustro Comments

Discuss this Deal with other Investors

Norbert Health

A groundbreaking device that measures all essential vital signs without contact

Claim My Business
Security Type
Technology, Financial Services, Healthcare & Medical, Retail
Min Investment
Expected Close Date
April 29, 2024
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Key Deal Facts

Repeat tech entrepreneur built a device and AI to measure all vitals signs in 30s, medical accuracy. Combination of radar, infrared and advanced camera make it possible to measure all vitals accurately Clinical trials for certification in progress - target FDA approval date is Q4 2023 (not guaranteed) Ongoing pilots with major healthcare players like Northwell, NYU, Duke, Vivalto, SOS, Weill-Cornell Saeju Jeong, founder of Noom, invested and is a board member. $8M raised from top tier VCs, angels $265Bn worth of Medicare costs are moving to home care - and need automated vitals scanning devices! Manufacturing devices with major contract manufacturer in Q4 2023 in Europe 6 patents and De-Novo applications protect a unique and advanced AI and hardware technology

Management Team / Advisory Board Bios

Alexandre Winter CEO & Co-FounderA pioneer researcher in AI, Alex founded and exited two tech startups. LTU technologies built the first image based search engine and was acquired by a Japanese public company. Placemeter was a raised 10m from NEA and Qualcomm and was sold to Netgear., Ahmad Gaber Chief Commercial OfficerFounded three companies in Healthcare (digital health, biotech, primary care), led corporate strategy at Premier Inc, one of the largest healthcare services companies in the USA, Thomas Rosenblatt Chief Technology OfficerSoftware architect at Meta, led backend at Netatmo, John Backer VP of OperationsLed hardware and manufacturing at Tasso, long and deep expertise in medical hardware, manufacturing, QMS, regulatory and supply chain, Xin He Chief Medical OfficerGraduate of Yale and MIT with experience designing, running and publishing clinical studies. Practicing physician and Director of Endocrinology Department at Signature Healthcare outside Boston.

Amount Raised : $3,754,833
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter